1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Sclerosis: new trials by email Literature Review of Sclerosis trials Research Report on Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone Methylprednisolone, ACTH, IV placebo - Multiple Sclerosis | Phase 2 / Phase 3 | Terminated | Neurologique Foundation, Inc. | 30 | 2009-10-01 | 2016-03-22 |
Multiple Sclerosis (1) · Recurrence (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Adrenocorticotropic Hormone (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1)
Neurologique Foundation, Inc. (1)
United States (1)